LivaNova PLC
NASDAQ:LIVN

  • LAST PRICE
    51.3200
  • TODAY'S CHANGE (%)
    -0.3800 (-0.7350%)
  • Bid / Lots
    50.1000/ 2
  • Ask / Lots
    52.4900/ 1
  • Open / Previous Close
    51.6500 / 51.7000
  • Day Range
    50.5500
    51.8732
  • 52 Week Range
    42.7500
    64.4750
  • Volume
    400,585

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Medical Equipment, Supplies & Distribution Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
LIVN
LivaNova PLC
2.8B
120.5x
---
WRBY
Warby Parker Inc
2.8B
-84.6x
---
NEOG
Neogen Corp
3.2B
-137.9x
---
CNMD
Conmed Corp
2.2B
17.7x
+8.12%
NARI
Inari Medical Inc
2.9B
-36.7x
---
ENOV
Enovis Corp
2.6B
-21.1x
---
As of 2024-11-22

Company Information

LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, Neuromodulation and Advanced Circulatory Support (ACS). Cardiopulmonary segment is engaged in the design, development, manufacture, marketing and selling of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula and other related accessories. It includes the Essenz Perfusion System, the Company’s next-generation HLM with an embedded patient monitor for tailored patient care strategies. Neuromodulation segment is engaged in the design, development, manufacture, marketing and selling of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). The ACS segment is engaged in the development, production, and sale of temporary life support products.

Contact Information

Headquarters
20 Eastbourne TerraceLONDON, United Kingdom W2 6LG
Phone
203-325-0662
Fax
---

Executives

Independent Chairman of the Board
William Kozy
Chief Executive Officer, Director
Vladimir Makatsaria
Chief Financial Officer
Alex Shvartsburg
President, Global Epilepsy
Stephanie Bolton
Senior Vice President, Chief Legal Officer, Corporate Secretary
Michael Hutchinson

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$2.8B
Revenue (TTM)
$1.2B
Shares Outstanding
54.3M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.98
EPS
$0.43
Book Value
$23.70
P/E Ratio
120.5x
Price/Sales (TTM)
2.3
Price/Cash Flow (TTM)
41.4x
Operating Margin
-2.19%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.